These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33360734)

  • 21. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL.
    Bartholomew TS; Onugha J; Bullock C; Scaramutti C; Patel H; Forrest DW; Feaster DJ; Tookes HE
    Harm Reduct J; 2020 Jun; 17(1):40. PubMed ID: 32522201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpersonal and structural factors associated with receptive syringe-sharing among a prospective cohort of female sex workers who inject drugs.
    Park JN; Footer KHA; Decker MR; Tomko C; Allen ST; Galai N; Sherman SG
    Addiction; 2019 Jul; 114(7):1204-1213. PubMed ID: 30694587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cross-sectional assessment of injection of "salts" and HIV transmission-related behaviours among a cohort of people who inject drugs in Kyrgyzstan.
    Kennedy R; Bouck Z; Werb D; Kurmanalieva A; Blyum A; Shumskaya N; Patterson TL; Cepeda JA; Smith LR
    J Int AIDS Soc; 2024 Jul; 27(7):e26247. PubMed ID: 38978392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada.
    Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J
    J Viral Hepat; 2019 Dec; 26(12):1413-1422. PubMed ID: 31433888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual HIV risk and vulnerabilities among people who inject drugs in Iran: Findings from a nationwide study in 2020.
    Mehmandoost S; Khezri M; Aghaali N; Shokoohi M; Haghdoost AA; Tavakoli F; Sharifi H; Karamouzian M
    Harm Reduct J; 2024 Oct; 21(1):187. PubMed ID: 39425102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of audio computer assisted self-interview and face-to-face interview methods in eliciting HIV-related risks among men who have sex with men and men who inject drugs in Nigeria.
    Adebajo S; Obianwu O; Eluwa G; Vu L; Oginni A; Tun W; Sheehy M; Ahonsi B; Bashorun A; Idogho O; Karlyn A
    PLoS One; 2014; 9(1):e81981. PubMed ID: 24416134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran.
    Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Bahramnejad A; Barshan A; Mousavian G; Najafi E; Sharifi H; Haghdoost AA; Briceno A; McFarland W; Page K
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):56. PubMed ID: 32758246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
    AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV elimination.
    Kåberg M; Navér G; Hammarberg A; Weiland O
    J Viral Hepat; 2018 Dec; 25(12):1452-1461. PubMed ID: 29998522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
    MacArthur GJ; van Velzen E; Palmateer N; Kimber J; Pharris A; Hope V; Taylor A; Roy K; Aspinall E; Goldberg D; Rhodes T; Hedrich D; Salminen M; Hickman M; Hutchinson SJ
    Int J Drug Policy; 2014 Jan; 25(1):34-52. PubMed ID: 23973009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study.
    Cunningham EB; Hajarizadeh B; Amin J; Bretana N; Dore GJ; Degenhardt L; Larney S; Luciani F; Lloyd AR; Grebely J;
    Int J Drug Policy; 2018 Apr; 54():18-25. PubMed ID: 29367011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.
    Bruneau J; Lamothe F; Franco E; Lachance N; Désy M; Soto J; Vincelette J
    Am J Epidemiol; 1997 Dec; 146(12):994-1002. PubMed ID: 9420522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of Transactional Sex and Violent Victimization among Men Who Inject Drugs in Los Angeles and San Francisco, California.
    Walters SM; Kral AH; Lamb S; Goldshear JL; Wenger L; Bluthenthal RN
    J Urban Health; 2021 Feb; 98(1):70-82. PubMed ID: 33409836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
    Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
    Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.
    Farooq A; Valerio H; Wheeler A; Martinello M; Henderson C; Silk D; Degenhardt L; Read P; Dore GJ; Grebely J; Cunningham EB;
    Drug Alcohol Rev; 2024 May; 43(4):1019-1028. PubMed ID: 38630939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington.
    Glick SN; Burt R; Kummer K; Tinsley J; Banta-Green CJ; Golden MR
    Drug Alcohol Depend; 2018 Jan; 182():86-92. PubMed ID: 29175463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z
    AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk behaviour determinants among people who inject drugs in Stockholm, Sweden over a 10-year period, from 2002 to 2012.
    Karlsson N; Santacatterina M; Käll K; Hägerstrand M; Wallin S; Berglund T; Ekström AM
    Harm Reduct J; 2017 Aug; 14(1):57. PubMed ID: 28814336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.